About Joseph Gentile
Joseph Gentile is a director at Biometry.
Joseph Gentile first appears on SEC filings in 2024.
Experience
This experience comes from Joseph Gentile's profile and from SEC filings. For roles taken from filings, the years are when the filings name Joseph Gentile in the role, so the role may have started earlier or lasted longer.
MI
MicrofluidX Current
Board Member
2023 – Present
BS
Boston Cell Standards Current
Board Member
2020 – Present
QI
QSM Diagnostics, Inc Current
Board Member
2020 – Present
AI
Anodyne Nanotech, Inc Current
Strategic Advisor
2020 – Present
Biometry Inc. Current
Member Board Of Directors
2019 – Present · Lowell, MA
Develops breath monitoring technology for people with asthma and COPD.
KY
Kytopen
Chairman of the Board of Directors
2025 – 2026
II
iVexSol, Inc.
Member Board of Directors
2022 – 2025
QI
Quantum Diamond Technologies Inc
Strategic Advisor
2017 – 2025
SD
SeLux Diagnostics
Strategic Advisor
2016 – 2025
CB
Clara Biotech
Member Board Of Directors
2021 – 2023
EI
Erbi Biosystems, Inc.
Board Member
2021 – 2022
CL
Cellaria Biosciences, LLC
Executive Chairman
2016 – 2021
TB
TiE Boston
Member of the Board
2014 – 2021
KH
Key Biologics Holdings
Board Of Directors (2019 – 2020)
President and Chief Executive Officer (2018 – 2019)
2018 – 2020
GI
Genometry, Inc
Board Advisor
2012 – 2020
AT
Adeo Health Science (formerly Anthera Therapeutics)
Board Advisor
2016 – 2019
QT
Quad Technologies
Board Advisor
2015 – 2018
QU
Quanterix
Senior Vice President
2017
SC
Stemgent Inc - A ReproCELL Group Company
Chief Executive Officer
2009 – 2016
Key Colleagues at Startups
The people Joseph Gentile works with at each company, as listed on that company's latest Form D.
Biometry Inc. · Form D/A, Jul 23, 2026
